Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 and has quickly become a worldwide pandemic. In response, many diagnostic manufacturers have developed molecular assays for SARS-CoV-2 under the Food and Drug Administration (FDA) Emergency Use Authori...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Elizabeth, Zhen, Wei, Manji, Ryhana, Schron, Deborah, Duong, Scott, Berry, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448672/
https://www.ncbi.nlm.nih.gov/pubmed/32571894
http://dx.doi.org/10.1128/JCM.01134-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448672/
https://www.ncbi.nlm.nih.gov/pubmed/32571894
http://dx.doi.org/10.1128/JCM.01134-20

Ejemplares similares